{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T03:57:43Z","timestamp":1768622263197,"version":"3.49.0"},"reference-count":7,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2025.51209","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T16:30:37Z","timestamp":1768581037000},"page":"e2551209","source":"Crossref","is-referenced-by-count":0,"title":["Observational Evidence and Value in Advanced Prostate Cancer\u2014Old Drugs, New Data"],"prefix":"10.1001","volume":"9","author":[{"given":"Divya A.","family":"Parikh","sequence":"first","affiliation":[{"name":"Department of Medicine, Stanford University, Stanford, California"},{"name":"VA Palo Alto Health Care System, Palo Alto, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Dietrich","sequence":"additional","affiliation":[{"name":"Department of Medicine, Stanford University, Stanford, California"},{"name":"VA Palo Alto Health Care System, Palo Alto, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John T.","family":"Leppert","sequence":"additional","affiliation":[{"name":"Department of Medicine, Stanford University, Stanford, California"},{"name":"Department of Urology, Stanford University, Stanford, California"},{"name":"VA Palo Alto Health Care System, Palo Alto, California"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"issue":"28","key":"zic250360r1","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.1200\/JCO.2016.72.1068","article-title":"Cabazitaxel versus docetaxel as first-line therapy for patients with metastatic castration-resistant prostate cancer: a randomized phase III trial\u2014FIRSTANA.","volume":"35","author":"Oudard","year":"2017","journal-title":"J Clin Oncol"},{"issue":"26","key":"zic250360r2","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1056\/NEJMoa1911206","article-title":"Cabazitaxel versus abiraterone or enzalutamide in metastatic prostate cancer.","volume":"381","author":"de Wit","year":"2019","journal-title":"N Engl J Med"},{"issue":"1","key":"zic250360r3","article-title":"Docetaxel rechallenge vs cabazitaxel in patients with metastatic castration-resistant prostate cancer.","volume":"9","author":"Barata","year":"2026","journal-title":"JAMA Netw Open"},{"issue":"3","key":"zic250360r4","doi-asserted-by":"publisher","first-page":"402","DOI":"10.7326\/ANNALS-24-01871","article-title":"The target trial framework for causal inference from observational data: why and when is it helpful?","volume":"178","author":"Hern\u00e1n","year":"2025","journal-title":"Ann Intern Med"},{"issue":"24","key":"zic250360r5","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1001\/jama.2022.21383","article-title":"Target trial emulation: a framework for causal inference from observational data.","volume":"328","author":"Hern\u00e1n","year":"2022","journal-title":"JAMA"},{"issue":"1","key":"zic250360r6","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1186\/s12913-022-08274-x","article-title":"An economic evaluation of cabazitaxel versus a second androgen receptor-targeted agent (ARTA) for patients with metastatic castration-resistant prostate cancer previously treated with docetaxel and an ARTA: the United States payer perspective.","volume":"22","author":"Morgans","year":"2022","journal-title":"BMC Health Serv Res"},{"issue":"3","key":"zic250360r7","doi-asserted-by":"publisher","first-page":"140","DOI":"10.6004\/jnccn.2024.0019","article-title":"NCCN Guidelines Insights: prostate cancer, version 3.2024.","volume":"22","author":"Schaeffer","year":"2024","journal-title":"J Natl Compr Canc Netw"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2844046\/parikh_2026_ic_250360_1767982503.96855.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T16:30:38Z","timestamp":1768581038000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2844046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":7,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.51209","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]}}}